Salarius Pharmaceuticals, Inc. — Director's Dealing 2015

Nov 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2015-11-11

Reporting Person: HAHN MARINA (President, Consumer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-11	Stock Option (right to buy)	$11.05	A	150000	Acquired	2025-11-11	Common Stock (150000.0)	Direct

Footnotes

F1: The stock option will vest based on performance criteria for which the Issuer has requested confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended.